Normand Brown

Media Arts Group, Inc. designs, manufactures, and markets artistic products based on the works of artist Thomas Kinkade. The company is headquartered in San Jose, CA.

Roche Pharmaceuticals provides research and development services in the fields of pharmaceuticals and diagnostics. It also provides diagnostics and drugs for cancer and transplantation. The company is headquartered in Nutley, NJ.

Alkahest, Inc. operates as biopharmaceutical company. It focuses on developing of treatments for neurodegenerative and age-related diseases. The company is headquartered in San Carlos, CA.

Aventis Pharmaceuticals, Inc. develops, manufactures and markets pharmaceutical products. The company was founded in 1950 and is headquartered in Bridgewater, NJ.

Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA.

University of Washington functions as a College/University. The company is headquartered in Seattle, WA.

Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ.

Global Factory, Inc. provides collaborative manufacturing execution systems. The firm's software gather, organize & analyze demand, production & quality data from various sources and monitor key indicators & execute business processes to control, manage & optimize distributed manufacturing operations. The company was founded in 1999 and is headquartered in Santa Clara, CA.

Novartis Groupe France SA is a pharmaceutical company. It provides cure for diseases. The company is headquartered in Rueil-Malmaison, France.

Part of Roche Holding AG, Roche Diagnostics KK is a Japanese company that manufactures and sells medical equipment. The company is based in Tokyo, Japan. The company was founded in 1932. The CEO is Shin Ogasawara.

REGiMMUNE Corp. develops solutions for treating immune disorders. Its focus is on the discovery, development, and commercialization of immune regulatory therapeutics to treat life-threatening and debilitating conditions, including allergies, autoimmune diseases and transplantation. The firm's platform technology, reVax, induces immune tolerance in an antigen-specific manner through pharmacological induction of regulatory T (Treg) cells. It also develops products for preventing inhibitor formation in enzyme replacement therapies (ERT) and for celiac disease with undisclosed partners. The company was founded by Yasuyuki Ishii on March 3, 2006 and is headquartered in Tokyo, Japan.

Part of Elanco Animal Health, Inc., Novartis Animal Health US, Inc. manufactures pharmaceutical products for animals. The company is based in Greensboro, NC.

Medichem SA is a vertically Spanish integrated pharmaceutical company that specializes in the development and manufacture of APIs and FDFs for the generics market. The company is based in Sant Joan Despi, Spain, and has subsidiaries in Spain. The company offers highly potent active pharmaceutical ingredients (HPAPI) manufacturing, from development to cGMP production, and have an R & D laboratory and GMP kilo-lab. Medichem offers specific chlorhexidine transparent aqueous and alcoholic solutions based on chlorhexidine digluconate as an active ingredient, with a wide range of applications such as pharma, biocide, oral care, cosmetics, and veterinary. The company's chlorhexidine wipes are used for general disinfection. The company was founded in 1972, and José Luis Rodríguez has been the CEO of the company since 1996.

MBS Value Partners, Inc. is an investor relations and financial communications advisory company. The private company is based in New York, NY and has subsidiaries in the United States and Brazil. The company was founded by Lynn Morgen and Margaret Mager has been the CEO of the company since 2015.

Nexvet Australia Pty Ltd. operates as a global clinical-stage biopharmaceutical company that develops and distributes medicines for companion animals. The firm focuses on transforming the therapeutic market by developing and commercializing novel biologic therapies, including products derived from its PETization technology. PETization is designed to rapidly create monoclonal antibodies that are recognized as “self” by a patient’s immune system. The company was founded by Mark Heffernan, Christopher Nigel Brown and David Gearing in February 2010 and is headquartered in Melbourne, Australia.

Balance Therapeutics, Inc. develops therapeutics to address conditions of intellectual disability. Its pharmacological approach, based on technology licensed from Stanford University, hypothesizes that restoring the proper balance between inhibition and excitation at the neuronal synapse by antagonizing excessive inhibitory circuits could result in the appropriate plasticity for memory and learning to occur in many conditions of intellectual disability. The company was founded by Lyndon Lien, Craig Garner and Daniel Wetmore in 2009 and is headquartered in San Bruno, CA.

Neuropore Therapies, Inc. provides biopharmaceutical services. It also offers alpha-synuclein (ASYN), amyloid beta, autophagy, and publications programs. The company was founded by Eliezer Masliah in 2008 and is headquartered in San Diego, CA.

Nanoly Bioscience, Inc. develops polymers that enable temperature-sensitive molecules to survive without refrigeration. The firm develops a polymer, NanoShield that may be blended with any protein-based molecules to eliminate refrigeration. It can be applied to enzymes and reagents, anti-body drugs, viral vaccines, adjuvant-containing vaccines and therapeutics. The company was founded by Nanxi Liu and Balaji Sridhar and is headquartered in Denver, CO.

XFactor Ventures (XFactor Ventures) is a venture capital subsidiary of Exeter Venture Management Company LLC founded in 2017 by Anna B. Palmer and Chip M. Hazard. The firm is headquartered in Boston, Massachusetts.

Blaze Technology, Inc. is an AI-powered platform that helps businesses build software and apps to improve their operations. Blaze Technology is based in Los Angeles, CA, and has subsidiaries in the United States. The platform offers simple and transparent pricing, allowing users to pay only for what they need. With Blaze, users can create and launch internal tools, custom web apps, and more. The platform also provides SQL, MongoDB, and PostgreSQL admin consoles that are easy to create and edit. Additionally, Blaze offers a visual editor that allows users to combine and search customer data, search for orders, and update contact information without any coding. The company provides real-time visibility and analytics on inventory to teams and creates an automated and fully custom system to know when to restock. The company was founded in 2021 by Bruno Denuit, Nanxi Liu, and Justyna Wojcik, with Nanxi Liu serving as the CEO since 2021.

Vetmab Biosciences, Inc. is an American company that is developing life-changing therapeutics for pets. The company specializes in monoclonal antibodies (mabs) for modern veterinary practices. The CEO of the company is Denise Marie Bevers.

Grupo Proeza SAPI de CV is a holding company with interests in the automotive, healthcare, and food production industries. It fabricates and commercializes structural metal components for vehicles, operates a network of health service providers, and manufactures citrus fruit juices, concentrates and purees. The company was founded in 1988 and is headquartered in Monterrey, Mexico.

Aragen Bioscience, Inc. operates as a contract research organization focused on accelerating product development through science, professionalism and innovation. Its services include antibody discovery, protein science, efficacy testing, and cell line development. The company was founded by Rick Srigley in 1993 and is headquartered in Morgan Hill, CA.